ArticleJournal of cancer research and clinical oncology2025

The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study.

Keiichiro Suminaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.